Drug intelligence / Profile preview

Cdsquare-Pro

Development stage: Unknown
Lead developer: Golden Square Lab
Modality: Small Molecules
Administration: Oral

Overview

Cdsquare-Pro is an oral nutraceutical combination product from Golden Square for urinary tract infection support and prevention. It contains cranberry extract and d-mannose, two nonprescription ingredients commonly used to reduce bacterial adherence within the urinary tract; cranberry proanthocyanidins are generally understood to interfere with uropathogenic bacterial attachment to uroepithelial surfaces, while d-mannose can act as a soluble ligand decoy for mannose-sensitive bacterial adhesins such as type 1 fimbriae. The product appears to be marketed in India as a dietary supplement rather than a conventional pharmaceutical drug.

Brand names: Cdsquare-Pro
Other names: Cdsquare-Pro-Golden Square-Urinary tract infection (UTI)

Targets

FimH (Type 1 fimbrial adhesin)

Beyond the preview

Go deeper on Cdsquare-Pro.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cdsquare-Pro.

Explore the full profile